Physician profile
Gregory Miller
NPI 1356873368
$4,256.08
in general payments reported to CMS, 2019-2025
7 companies · $22.81 in 2025
The $22.81 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $251 · 2023: $474 · 2024: $3,373 · 2025: $22.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,248 · Food and Beverage: $1,456 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,248.47 |
| Food and Beverage | $1,456.43 |
| Education | $165.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,102.92 | 2023-2024 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,258.17 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $332.91 | 2022-2024 | |
| Teleflex LLC | $196.65 | 2024 | Manta |
| Shockwave Medical, INC | $174.12 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $168.50 | 2021-2023 | Farxiga |
| Abbvie INC. | $22.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.